摘要
胃癌是一常见疾病,在世界范围内,是第4位常见的恶性肿瘤。在导致死亡的恶性肿瘤疾病中位居第2,根治性手术后其5年生存率仅40%左右。手术切除病灶是现在唯一有可能治愈胃癌的方法,然而术后长期生存率在个体间差异很大。现就接受胃癌根治术后的患者的预后相关因素的研究进行综述。
出处
《实用医学杂志》
CAS
北大核心
2009年第3期337-338,共2页
The Journal of Practical Medicine
基金
上海交通大学科研基金赞助项目(编号:2007XJ032)
参考文献18
-
1陈凛,张勇,卫勃,赵向阳,李涛.2335例胃癌外科治疗的临床分析[J].中华胃肠外科杂志,2007,10(5):421-424. 被引量:33
-
2Luo T H, Fang G E, Bi J W, et al. The effect of perineural invasion on overall survival in patients with gastric carcinoma [J]. J Gastrointest Surg,2008,12(7) : 1263-1267.
-
3Saito H, Osaki T, Murakami D, et al. Macroscopic tumor size as a simple prognostic indicator in patients with gastric cancer [J]. Am J Surg, 2006, 192(3) :296-300.
-
4Marchet A, Mocellin S, Ambrosi A, et al. The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients [ J ]. Ann Surg, 2007, 245 (4) : 543-552.
-
5Nitti D, Marchet A, Olivieri M, et al. Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a .large European monoinstitutional experience [J]. Ann Surg Oncol, 2003, 10(9): 1077-1085.
-
6Lee E, Chae Y, Kim I, et al. Prognostic relevance of immunohistochemieally detected lymph node micrometastasis in patients with gastric carcinoma [J]. Cancer, 2002, 94 (11) :2867- 2873.
-
7Katsuragi K, Yashiro M, Sawada T, et al. Prognostic impact of PCR-based identification of isolated tumour cells in the peritoneal lavage fluid of gastric cancer patients who underwent a curative R0 resection [J]. BrJ Cancer, 2007, 97(4):550-556.
-
8Tamura N, Iinuma H, Takada T. Prospective study of the quantitative carcinoembryonic antigen and cytokeratin 20 mRNA detection in peritoneal washes to predict peritoneal recurrence in gastric carcinoma patients [J]. Oncol Rep,2007, 17(3) :667-672.
-
9Jin S P, Kim J H, Kim M A, et al. Prognostic significance of loss of c-fos protein in gastric carcinoma: pathology oncology research [J]. 2007, 13(4): 284-289.
-
10i Mattioni M, Soddu S, Porrello A, et al. Serum anti-p53 antibodies as a useful marker for prognosis of gastric carcinoma [J]. Int J Biol Markers, 2007, 22(4) : 302-306.
二级参考文献7
-
1徐大志,詹友庆.胃癌切缘残留癌[J].国外医学(肿瘤学分册),2004,31(7):532-534. 被引量:3
-
2詹友庆,李威,孙晓卫,陈映波,徐立,陈功,关远祥,李元方,徐大志,孙献甫,张华政,林振文.胃癌外科治疗的远期疗效研究[J].中华外科杂志,2005,43(17):1109-1113. 被引量:82
-
3Allgayer H, Heiss MM, Schildberg FW, et al. Prognostic factors in gastric carcer. Br J Surg, 1997,84: 1651-1664.
-
4Maehara Y, Kakeji Y, Koga T, et al. Therapeutic value of lymph node dissection and the clinical outcome for patients with gastric cancer. Surgery, 2002, 131(1s) :S85-91.
-
5Liu KJ,Atten MJ,Donahue PE,et al. Extended lymphadenectomy for gastric cancer:results in a teaching hospital. Am J Surg, 2002,68 : 365-371.
-
6张祥福,黄昌明,卢辉山,吴心愿,张建中,郑朝晖,官国先,王川,周永建,宋传贵.胃癌外科治疗与预后的临床观察[J].中华医学杂志,2002,82(16):1142-1143. 被引量:14
-
7孙秀娣,牧人,周有尚,戴旭东,张思维,皇甫小梅,孙杰,李连弟,鲁凤珠,乔友林.中国胃癌死亡率20年变化情况分析及其发展趋势预测[J].中华肿瘤杂志,2004,26(1):4-9. 被引量:701
共引文献32
-
1Zhen Wang,Jun-Qiang Chen,Yun-Fei Cao,Department of Gastrointestinal Surgery,the First Affiliated Hospital of Guangxi Medical University,6 Shuangyong Road,Nanning 530021,Guangxi Zhuang Autonomous Region,China.Systematic review of D2 lymphadenectomy versus D2 with para-aortic nodal dissection for advanced gastric cancer[J].World Journal of Gastroenterology,2010,16(9):1138-1149. 被引量:2
-
2曹晖,赵恩昊.早期胃癌的诊断和外科手术进展[J].消化肿瘤杂志(电子版),2010,2(1):14-16. 被引量:2
-
3蔡世荣,陈剑辉,陈创奇,马晋平,宋武,何裕隆,詹文华.不同时期胃癌临床病理特点及预后比较[J].消化肿瘤杂志(电子版),2008(2).
-
4Ding-Feng Shen Da-Wei Chen Zhi-Wei Quan Ping Dong Xue-Feng Wang Hai-Zhou Xu Ming-Lin Zhao Lei Chen.Dissection of No.13 lymph node in radical gastrectomy for gastric carcinoma[J].World Journal of Gastroenterology,2008,14(6):936-938. 被引量:17
-
5蔡世荣,陈创奇,马晋平,陈剑辉,宋武,何裕隆,詹文华.不同时期胃癌的临床病理特点及预后比较分析[J].中华医学杂志,2009,89(18):1264-1268. 被引量:6
-
6李小宝,张洪伟,赵青川,董光龙,王为忠.1031例胃癌外科治疗预后的多因素分析[J].中华胃肠外科杂志,2010,13(2):115-118. 被引量:18
-
7刘翔宇,梁寒,邓靖宇,潘源,张李.不同部位胃癌患者根治术后临床病理特点及预后分析[J].中华胃肠外科杂志,2010,13(3):181-184. 被引量:14
-
8俞鹏飞,郭剑民,徐琦,应杰儿,王晓稼,程向东,王新保,余传定.耐药基因相关蛋白在胃癌术后辅助化疗及预后评价中的意义[J].中华胃肠外科杂志,2010,13(4):289-293. 被引量:9
-
9臧洲,刘凭,孙强,李华冰.全部胃小弯切除在远侧胃癌根治术中的应用[J].蚌埠医学院学报,2010,35(9):912-913. 被引量:4
-
10Ai-wen Wu Jia-fu Ji Hong Yang Yan-ning Li Shuang-xi Li Lian-hai Zhang Zi-yu Li Xiao-jiang Wu Xiang-long Zong Zhao-de Bu Ji Zhang Xiang-qian Su Yi Wang Guang-wei Xu.长期结果一胃癌患者在中国大型系列[J].Chinese Journal of Cancer Research,2010,22(3):167-175. 被引量:7
同被引文献16
-
1季加孚.胃癌外科的现状与发展趋势[J].中国普外基础与临床杂志,2006,13(1):1-3. 被引量:65
-
2Dong Yi Kim,Kyeung Won Seo,Jae Kyoon Joo,Young Kyu Park,Seong Yeob Ryu,Hyeong Rok Kim,Young Jin Kim,Shin Kon Kim.Prognostic factors in patients with node-negative gastric carcinoma:A comparison with node-positive gastric carcinoma[J].World Journal of Gastroenterology,2006,12(8):1182-1186. 被引量:20
-
3Ze-Yu Wu,Jing-Hua Li,Wen-Hua Zhan,Yu-Long He.Lymph node micrometastasis and its correlation with MMP-2 expression in gastric carcinoma[J].World Journal of Gastroenterology,2006,12(18):2941-2944. 被引量:33
-
4彭淑牖.晚期胃癌不要轻易放弃手术切除的机会[J].中国实用外科杂志,2001,21:400-401.
-
5Barbour AP,Rizk NP,Gonen M,et al. Lymphadeneetomy for adenocarcinoma of the gastrosophageal junction (GEJ) impact of adequate staging on outcome[J]. Ann Surg Oncol, 2007,14 (2) 306 316.
-
6AL-Moundhri MS, A1-Bahrani B, Burney IA, et al. The prog nostic determinants of gastric cancer treatment outcome in Omani Arab patientsEJ ]. Oncology, 2006,70 (2) : 90-96.
-
7Wilke H,Preusser P,FinkU,et al. Preoperative chemotherapy in locally advanced and nonrescetable gastric cancera phase II study with etoposide, doxorubicin,and cisplatin[J].J Clin On- co1,1989,7(9)1318-1326.
-
8Persiani R, Dugo D, Rausei S, et al. Prognostic indicators in 1o cally advanced gastric cancer(LAGC)treated with preoperative chemotherapy and D2-gastrectomy[J]. J Surg Oncol, 2005,89 (4) 227 236.
-
9杨永栋,阿不都外力.吾守尔,陈兵,王云海,李涛,文西年.胃癌淋巴结转移规律的研究[J].新疆医科大学学报,2007,30(8):824-826. 被引量:6
-
10Park Do Y,Srivastava A,Kim G H,et aL CDX2 expression in the intestinal -type gas- tric epithelial neoplasia:frequency and significance. Mod Pathol,2010,23(1) :54-61.
引证文献3
-
1吴泽宇,彭林,赵刚,詹文华.淋巴结微转移检测对判断胃癌预后的价值[J].实用医学杂志,2010,26(22):4151-4153. 被引量:3
-
2杨永栋,肖永彪,李新伟,胡志良,阿里木江.阿布拉,阿布都.艾尼.胃癌新辅助化疗对转移性淋巴结的治疗效果分析[J].新疆医科大学学报,2013,36(11):1621-1624. 被引量:2
-
3张毅,张品南,郑志强,董建达,郭群.老年人胃腺癌临床病理多因素与预后关系的研究[J].医学与社会,2015,28(B06):123-123.
二级引证文献5
-
1杨宇辉,丘波,邹浩元,周铭,杨宇扬,赖春凤.梅州客家人群非饮食因素与胃癌的关系[J].实用医学杂志,2011,27(24):4492-4495. 被引量:1
-
2陈镇武,文武魁,黄伟涛.血管脉络化解剖法在胃癌D2根治术中的应用[J].实用医学杂志,2013,29(8):1364-1365. 被引量:3
-
3张志栋,刘庆伟,李勇,赵群,范立侨,焦志凯,赵雪锋,王冬,刘羽.纳米炭在局部进展期胃癌术前化疗后淋巴结检获中的应用价值[J].中国全科医学,2016,19(2):179-183. 被引量:12
-
4丁志,周祥,徐锐,赵平.术前辅助化疗对胃癌患者手术并发症及生活质量的影响[J].解放军医药杂志,2019,31(1):22-25. 被引量:6
-
5邹若凡,戴光荣.胃癌淋巴结微转移的研究进展[J].临床医学进展,2022,12(3):1801-1806.
-
1刘自明,严律南,李馨筱.胰腺癌患者行胰十二指肠切除术后长期生存率的影响因素[J].华西医学,2007,22(4):740-741. 被引量:1
-
2陆晓哲,王安喜,卓文利,管玉斌.术前化疗对儿童肾母细胞瘤手术疗效的影响[J].人民军医,2008,51(10):650-651. 被引量:1
-
3臧淑伟,丁红娟,惠利,马怡,彭光群.盐酸羟考酮控释片治疗癌痛不良反应的观察及护理[J].中国实用护理杂志,2006,22(1):46-46. 被引量:1
-
4刘敏,王朝晖,周桂兰,吕文良.体外肿瘤细胞培养法对非小细胞肺癌化疗药物敏感性的研究[J].大连医科大学学报,2009,31(1):64-66. 被引量:7
-
5张实玉.nm23—H1的表达与食管癌预后的关系[J].华夏医药,2001,5(2):40-41.
-
6张宝玉,黄晓红,洪丰,石男.CEA的表达与食管癌预后的关系[J].济宁医学院学报,2001,24(2):47-47.
-
7徐启明,周乃康,刘颖,杨成秀.58例肺大细胞癌的诊断和外科治疗[J].中国肿瘤临床,2008,35(1):15-17. 被引量:13
-
8刘国兵,李艳丽,胡鹏程,石洪成.P ET/CT显像中肝脏18 F-FDG摄取的影响因素[J].中华核医学与分子影像杂志,2015,35(6):506-508. 被引量:12
-
9文摘[J].药品评价,2012(25):4-4.
-
10沈琳.精准医疗快速发展时期结直肠癌治疗沉淀与突破[J].南京医科大学学报(自然科学版),2016,36(3):261-263. 被引量:7